National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Endometrial Cancer Screening (PDQ®)     
Last Modified: 06/24/2009
Health Professional Version
Changes To This Summary (06/24/2009)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Summary of Evidence 1

Revised text 2 to state that there is no evidence that screening by ultrasonography reduces mortality from endometrial cancer.

Significance 3

Updated incidence and mortality estimates 4 for 2009 (cited American Cancer Society as reference 1).

Evidence of Benefit 5

Added text 6 on the accuracy of transvaginal ultrasound among asymptomatic women.

Added section 7 on ultrasonography in women using tamoxifen.


Table of Links

1http://www.cancer.gov/cancertopics/pdq/screening/endometrial/HealthProfessional
/1.cdr#Section_1
2http://www.cancer.gov/cancertopics/pdq/screening/endometrial/HealthProfessional
/177.cdr#Section_177
3http://www.cancer.gov/cancertopics/pdq/screening/endometrial/HealthProfessional
/12.cdr#Section_12
4http://www.cancer.gov/cancertopics/pdq/screening/endometrial/HealthProfessional
/14.cdr#Section_14
5http://www.cancer.gov/cancertopics/pdq/screening/endometrial/HealthProfessional
/18.cdr#Section_18
6http://www.cancer.gov/cancertopics/pdq/screening/endometrial/HealthProfessional
/95.cdr#Section_95
7http://www.cancer.gov/cancertopics/pdq/screening/endometrial/HealthProfessional
/181.cdr#Section_181